Skip to main content

HomeResearchAICAR

PerformanceMedium RiskResearch Only

AICAR

Acadesine · AICA ribonucleotide · 5-aminoimidazole-4-carboxamide ribonucleotide

CategoryPerformance
Half-life
Routesubcutaneous, intravenous
RiskMedium Risk
Providers1 listed

About AICAR

Converted intracellularly to ZMP, a potent AMPK activator. AMPK activation increases fatty acid oxidation, glucose uptake, and mitochondrial biogenesis — the same metabolic pathways activated by sustained aerobic exercise.

A cell-permeable nucleoside analog that activates AMPK, mimicking cellular exercise signals. Studied for endurance enhancement and metabolic disease research. Not a true peptide — a synthetic nucleoside frequently sold by peptide vendors.

Research Areas

endurancefat oxidationmitochondrial biogenesisAMPK activation

Regulatory & Evidence

Risk Profile

Medium Risk

Moderate risk profile in research contexts. Review contraindications and administration guidelines before use.

Regulatory Status

Availability Status
Research Only

Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

Where to Find AICAR

1 provider

Newsletter

The Peptide Research Digest

New providers, emerging stacks, and research developments — weekly.

No spam. Unsubscribe anytime. Privacy policy.